• Advanced technologies

    Advanced technologies. Our plant is compliant with Good Manufacturing Practice (GMP) standards and produces active pharmaceutical ingredients from recombinant micro organisms. This plant, together with a highly experienced R&D department, serves as the foundation for implementation of the company's strategic plans.

    More about advanced technologies
  • Social responsibility

    Sicor Biotech in its daily activities creates a balance between the well-being of its employees, customers, the society, and a healthy and safe environment.

    More about social responsibility
  • Global company

    The key of our success is the development of products for the global market. We produce formulations of recombinant biopharmaceuticals that are efficiently used to treat patients in various countries. Drug products produced by the Lithuanian scientists have been registered in the EU, Switzerland, Israel and Brazil, their ongoing registration takes part in other states such as the USA, Australia, Russia, etc.

    More about Sicor Biotech
  • Products

    We continuously develop new biopharmaceuticals drug products and improve the existing formulations of drug products.

    More about our products
Last news

All news
Report an adverse   reaction to medicine

We work to keep our products safe. Please report any suspected adverse reactions. Report us